Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient
- PMID: 39161845
- PMCID: PMC11331947
- DOI: 10.1016/j.mmcr.2024.100664
Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient
Abstract
Purpureocillium lilacinum and Fusarium species are increasingly recognized as significant opportunistic fungal pathogens. We report a rare case of co-infection in a 63-year old heart transplant recipient presenting with nodular skin lesions, treated successfully with voriconazole. We highlight the importance of being vigilant about co-infection with moulds as it impacts on the selection of appropriate antifungal agents. 2012 Elsevier Ltd. All rights reserved.
Keywords: Fusarium; Mycosis; Purpureocillium; Transplant; Voriconazole.
© 2024 The Authors.
Figures
References
-
- Pappas P.G., Alexander B.D., Andes D.R., et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin. Infect. Dis. 2010;50(8):1101–1111. - PubMed
-
- Hoenigl M., Salmanton-García J., Walsh T.J., Nucci M., Neoh C.F., Jenks J.D., et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European confederation of medical Mycology in cooperation with the international society for human and animal Mycology and the American society for microbiology. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(20)30784-2. - DOI - PubMed
-
- Sprute R., Salmanton-García J., Sal E., Malaj X., Ráčil Z., Ruiz de Alegría Puig C., et al. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature. J. Antimicrob. Chemother. 2021 May 12;76(6):1593–1603. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
